Literature DB >> 1021237

Comparative nephrotoxicity of platinum cancer chemotherapeutic agents.

J M Ward, D M Young, K A Fauvie, M K Wolpert, R Davis, A M Guarino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1021237

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  6 in total

1.  Biomonitoring of a worker population exposed to platinum dust in a catalyst production plant.

Authors:  F Petrucci; N Violante; O Senofonte; A Cristaudo; M Di Gregorio; G Forte; A Alimonti
Journal:  Occup Environ Med       Date:  2005-01       Impact factor: 4.402

2.  Inhibition of cis-platinum nephrotoxicity by diethyldithiocarbamate rescue in a rat model.

Authors:  R F Borch; M E Pleasants
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

3.  The antitumour effect and toxicity of cis-platinum and N-methylformamide in combination.

Authors:  E S Harpur; S P Langdon; S A Fathalla; J Ishmael
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  Platinum drugs: combined anti-lymphoproliferative and nephrotoxicity assay in rats.

Authors:  S K Aggarwal; J A Broomhead; D P Fairlie; M W Whitehouse
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

5.  Safety Profile of Rapamycin Perfluorocarbon Nanoparticles for Preventing Cisplatin-Induced Kidney Injury.

Authors:  Qingyu Zhou; Justin Doherty; Antonina Akk; Luke E Springer; Ping Fan; Ivan Spasojevic; Ganesh V Halade; Huanghe Yang; Christine T N Pham; Samuel A Wickline; Hua Pan
Journal:  Nanomaterials (Basel)       Date:  2022-01-21       Impact factor: 5.076

6.  Lack of nephrotoxicity of oral ammine/amine platinum (IV) dicarboxylate complexes in rodents.

Authors:  M J McKeage; S E Morgan; F E Boxall; B A Murrer; G C Hard; K R Harrap
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.